Never underestimate the power of cooperation and collective action to save lives. Who are you and what will you do on 4 Feb? Speak up, stand up and take action together this #WorldCancerDay#CloseTheCareGaphttp://worldcancerday.org
1/2: People in BC are set to benefit from expanded access to lifesaving cancer diagnostics & increased provincial capacity for nuclear medicine-based care & disease research with a new state-of-the art cyclotron & radiopharmacy laboratories in Vancouver.
https://ow.ly/4E7a50Qw7kS
Wishing you all a Happy New Year filled with joy, success, and good health! Here's to another year of advancements in #theranostics and patient care that is filled with innovation, compassion, and positive impact. Cheers to a fantastic 2024! #HappyNewYear#Innovation
Alisa Lattanzio likes being a PET/CT technologist because she makes a difference in people's lives. "That's something I hold close to my heart,” she says. Read what inspired others to choose similar careers as we celebrate #MRTWeek2023, at https://ow.ly/7lhL50Q69HY.
Congratulations to Dr. François Bénard, vice president of research at BC Cancer, who has won a Distinguished Service Award from the Western Region Society of Nuclear Medicine (WRSNM). Read more: https://ow.ly/2tMx50Q5MgY@frbenard@SNM_MI@UBCmedicine
A tool that can help us perform better quantitative imaging for personalization of #theranostics procedures
Quote
NMMItools
@NMMItools
·
Check out #PyTomography, the latest addition in
@NMMItools of @SNM_MI, an open-source, GPU-accelerated python library for quantitative #SPECT & #PET image #reconstruction by @Qurit lab from @BCCancer Luke Polson @ArmanRahmim@CarlosUribeMhttps://nmmitools.org/2023/10/19/pytomography/…
Very encouraging results, first-in-human 225Ac-DOTATATE Dosimetry Results from Part 1 of the ACTION-1 Trial, presented by Dr Gary Ulaner on behalf of Dr Michael Morris.
Join the community and help us expand beyond anatomical and other reconstruction priors that have already been implemented.
Let’s make it easy to implement new reconstruction ideas and test new methods.
Cassandra Miller proposing a method at the #eanm23 for dual isotope imaging in #RPTs for #prostatecancer that would allow identification of active bone marrow for dosimetry purposes.
Have you wondered why we don’t see toxicity in the great majority of patients? Isn’t that a sign of under treatment for most patients? How can we solve the “unknowns” to truly personalize RPTs?
As a PI, I’ve worked to ban the word “easy” from my vocabulary when talking about research.
Nothing is easy, and the longer we’re out of the lab, the more we tend to forget this.